XTX Topco Ltd lifted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 194.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 43,908 shares of the company's stock after acquiring an additional 29,006 shares during the period. XTX Topco Ltd's holdings in Intellia Therapeutics were worth $512,000 as of [...]
Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.